2. Academic Validation
  3. 1-(2,3-Dibenzimidazol-2-ylpropyl)-2-methoxybenzene Is a Syk Inhibitor with Anti-Inflammatory Properties

1-(2,3-Dibenzimidazol-2-ylpropyl)-2-methoxybenzene Is a Syk Inhibitor with Anti-Inflammatory Properties

  • Molecules. 2016 Apr 18;21(4):508. doi: 10.3390/molecules21040508.
Eunji Kim 1,  Young-Jin Son 2,  Yanyan Yang 3 4,  Ting Shen 5,  Ikyon Kim 6,  Adithan Aravinthan 7,  Jong-Hoon Kim 8,  Jae Youl Cho 9
Affiliations

Affiliations

  • 1 Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Korea. im144069@gmail.com.
  • 2 Department of Pharmacy, Sunchon National University, Suncheon 57922, Korea. sony@sunchon.ac.kr.
  • 3 Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Korea. orchid1201@hotmail.com.
  • 4 Medical College, Qingdao University, Qingdao 266071, China. orchid1201@hotmail.com.
  • 5 Jiangsu Collaborative Innovation Center of Regional Modern Agriculture & Environmental Protection/Jiangsu Key Laboratory for Eco-Agricultural Biotechnology around Hongze Lake, Huaiyin Normal University, Huaian 223300, China. shenting198612@hotmail.com.
  • 6 College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Korea. ikyonkim@yonsei.ac.kr.
  • 7 Department of Physiology, College of Veterinary Medicine, Chonbuk National University, Iksan 54596, Korea. aravinthchandra@gmail.com.
  • 8 Department of Physiology, College of Veterinary Medicine, Chonbuk National University, Iksan 54596, Korea. jhkim1@jbnu.ac.kr.
  • 9 Department of Genetic Engineering, Sungkyunkwan University, Suwon 16419, Korea. jaecho@skku.edu.
PMID: 27096863 DOI: 10.3390/molecules21040508
Abstract

Inflammation is the protective action of our bodies against external pathogens by recognition of pathogen-associated molecular patterns (PAMPs) via Pattern Recognition Receptors (PRRs). Proper regulation of inflammatory responses is required to maintain our body's homeostasis, as well as there are demands to develop proper acute or chronic inflammation. In this study, we elucidated the regulatory mechanism of NF-κB-mediated inflammatory responses by a novel compound, 1-(2,3-dibenzimidazol-2-ylpropyl)-2-methoxybenzene (DBMB). We found that DBMB suppressed inflammatory mediators, nitric oxide (NO) and prostaglandin E₂ (PGE₂), reacted to exposure to a number of toll like receptor (TLR) ligands. Such observations occurred following to decreased mRNA expression of several pro-inflammatory mediators, and such diminished mRNA levels were caused by inhibited transcriptional factor nuclear factor (NF)-κB, as evaluated by luciferase reporter assay and molecular biological approaches. To find the potential targets of DBMB, we screened phosphorylated forms of NF-κB signal molecules: inhibitor of κBα (IκBα), IκB kinase (IKK)α/β, Akt, 3-phosphoinositide dependent protein kinase-1 (PDK1), p85, and spleen tyrosine kinase (Syk). We found that DBMB treatment could suppress signal transduction through these molecules. Additionally, we conducted in vitro kinase assays using immunoprecipitated Syk and its substrate, p85. Consequently, we could say that DBMB clearly suppressed the kinase activity of Syk kinase activity. Together, our results demonstrate that synthetic DBMB has an effect on the inflammatory NF-κB signaling pathway and suggest the potential for clinical use in the treatment of inflammatory diseases.

Keywords

1-(2,3-dibenzimidazol-2-ylpropyl)-2-methoxybenzene; NF-κB; Syk; inflammatory responses.

Figures
Products